Home
Conditions
Melanoma

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies

Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00019214

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

NCT00082914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma

NCT00032045

Conditions: Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Recurrent or Refractory Metastatic Melanoma

NCT00019383

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

Isotretinoin in Preventing Skin Cancer

NCT00025012

Conditions: Carcinoma, Carcinoma, Basal Cell, Melanoma, +15 more
Locations: Intramural Research Program Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

NCT00005633

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic Melanoma

NCT00072085

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy and Interleukin-2 in Treating Patients With Metastatic Melanoma

NCT00054535

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Melanoma

NCT00020358

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00019994

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Melanoma

Melanoma trial results

Related conditions